Stocks / Biotech

KRYSBiotech

Krystal Biotech, Inc.
$346.581d +2.8%5d +4.3%settled close · 2026-08-21
Mkt cap $7.2B (3/25)β 0.4052w $262–381Shares 29.2MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2017Emp. 295HQ Pittsburgh, PAkrystalbio.com
Who’s talkingIdea Scout · free

Who’s talking about KRYS

No tracked investor commentary on KRYS yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
The options tape

Notable options days

Sessions in the last 120 where KRYS’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 9 of 120 sessions qualified.

The 5 most recent days are for Brief subscribers — the outcomes below are the free record.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-08-21
2026-08-03
2026-07-31
2026-07-24
2026-07-13
2026-06-18$356.003.4×$0M31.5%9.8%-4.7%
2026-06-17$341.667.4×$0M27.3%7.9%+6.0%
2026-06-15$324.759.3×$0M99.2%1.7%+7.8%
2026-05-14$311.192.3×$21M85.0%37.4%+2.3%
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on KRYS is in this morning’s Brief. Get The Brief — $20/mo →
Play history The Playbook · coming

Has a validated strategy ever fired on KRYS?

Has a validated strategy ever fired on KRYS — and how did the trades resolve? Even “never fired” is information.

Fire-by-fire history — play, entry, exit, result — is Playbook member content (coming).
FiredPlayEntry ExitResult
Every play carries a written validation gate, a spec, and a changelog. How plays are validated